Pulmonary arterial hypertension (PAH) is a lethal disease characterized by excessive proliferation of pulmonary vascular cells, such as endothelial cells (ECs). Hereditary (H) PAH is mainly caused by ―loss-of-function‖ mutations in the gene coding for the bone morphogenetic protein type II receptor (BMPR2). However, the mechanisms by which these mutations cause PAH remain unclear. The hypothesis of this thesis was that BMPR2 mutations produce an imbalance in EC protein expression and/or activity that is integrally related to the development of abnormalities in lung vascular function and structure in HPAH. Patient-specific blood-outgrowth endothelial cells (BOECs) expanded ex vivo from peripheral blood mononuclear cells from patients with HP...
RATIONALE: BMP9 (bone morphogenetic protein 9) is a circulating endothelial quiescence factor with p...
Rationale: BMP9 (bone morphogenetic protein 9) is a circulating endothelial quiescence factor with p...
Background: Pulmonary arterial hypertension (PAH) is a lethal vasculopathy. Hereditary cases are ass...
Pulmonary arterial hypertension (PAH) is a devastating disease characterized by abnormal remodeling ...
Pulmonary arterial hypertension (PAH) is a rare disease initiated by dysfunction of the pulmonary va...
Rationale: Dysfunction of endothelial cells is believed to be involved in the development of chronic...
Pulmonary arterial hypertension (PAH) is a rare and fatal disease caused by excessive remodelling of...
Background - Pulmonary arterial hypertension (PAH) is a rare but fatal lung disease of diverse origi...
Pulmonary arterial hypertension (PAH) is characterised by a fixed elevation in pulmonary artery pres...
Pulmonary arterial hypertension (PAH) is a devastating disease that is precipitated by hypertrophic ...
RATIONALE: Severe pulmonary arterial hypertension (PAH) is characterized by the formation of plexifo...
WOS: 000282728600004PubMed ID: 20819762Pulmonary arterial hypertension (PAH) is an uncommon disorder...
Rationale: Bone morphogenetic protein receptor type 2 (BMPR2) mutations are present in up to 70% of ...
© 2017 Dr Ling QianPulmonary arterial hypertension is a debilitating disease that results in obstruc...
Pulmonary arterial hypertension (PAH) is a progressive disease characterized by increased pulmonary ...
RATIONALE: BMP9 (bone morphogenetic protein 9) is a circulating endothelial quiescence factor with p...
Rationale: BMP9 (bone morphogenetic protein 9) is a circulating endothelial quiescence factor with p...
Background: Pulmonary arterial hypertension (PAH) is a lethal vasculopathy. Hereditary cases are ass...
Pulmonary arterial hypertension (PAH) is a devastating disease characterized by abnormal remodeling ...
Pulmonary arterial hypertension (PAH) is a rare disease initiated by dysfunction of the pulmonary va...
Rationale: Dysfunction of endothelial cells is believed to be involved in the development of chronic...
Pulmonary arterial hypertension (PAH) is a rare and fatal disease caused by excessive remodelling of...
Background - Pulmonary arterial hypertension (PAH) is a rare but fatal lung disease of diverse origi...
Pulmonary arterial hypertension (PAH) is characterised by a fixed elevation in pulmonary artery pres...
Pulmonary arterial hypertension (PAH) is a devastating disease that is precipitated by hypertrophic ...
RATIONALE: Severe pulmonary arterial hypertension (PAH) is characterized by the formation of plexifo...
WOS: 000282728600004PubMed ID: 20819762Pulmonary arterial hypertension (PAH) is an uncommon disorder...
Rationale: Bone morphogenetic protein receptor type 2 (BMPR2) mutations are present in up to 70% of ...
© 2017 Dr Ling QianPulmonary arterial hypertension is a debilitating disease that results in obstruc...
Pulmonary arterial hypertension (PAH) is a progressive disease characterized by increased pulmonary ...
RATIONALE: BMP9 (bone morphogenetic protein 9) is a circulating endothelial quiescence factor with p...
Rationale: BMP9 (bone morphogenetic protein 9) is a circulating endothelial quiescence factor with p...
Background: Pulmonary arterial hypertension (PAH) is a lethal vasculopathy. Hereditary cases are ass...